Low-molecular-weight heparin reduces neointimal proliferation after coronary stent implantation in hypercholesterolemic minipigs

• Published in: Circulation (New York, N.Y.) Vol. 86; no. 2; pp. 531 - 537
• Main Authors: BUCHWALD, A. B, UNTERBERG, C, NEBENDAHL, K, GRÖNE, H.-J, WIEGAND, V
• Format: Journal Article
• Language: English
• Published: Hagerstown, MD Lippincott Williams & Wilkins 01-08-1992
• Subjects: Animals; Biological and medical sciences; Blood. Blood coagulation. Reticuloendothelial system; Constriction, Pathologic - prevention & control; Coronary Vessels - drug effects; Coronary Vessels - pathology; Endothelium, Vascular - physiology; Female; Heparin, Low-Molecular-Weight - pharmacology; Hypercholesterolemia - pathology; Male; Medical sciences; Muscle, Smooth, Vascular - drug effects; Muscle, Smooth, Vascular - pathology; Pharmacology. Drug treatments; Stents; Swine; Swine, Miniature; Tantalum; Endoprosthesis; Coronary artery; Cardiovascular disease; Metabolic diseases; Smooth muscle; Coronary heart disease; Cholesterol; Pig; Prevention; Restenosis; Pathology; Vertebrata; Chemotherapy; Mammalia; Hypercholesterolemia; Treatment; Animal; Complication; Artiodactyla; Heparin; Ungulata
• ISSN: 0009-7322; 1524-4539
• DOI: 10.1161/01.CIR.86.2.531

Intracoronary stents have been suggested as a method of reducing the restenosis rate after balloon angioplasty. Proliferation of vascular smooth muscle cells is a major contributing factor to the restenosis process. Heparin and some of its derivatives have been shown to inhibit smooth muscle cell proliferation. We investigated the effect of low-molecular-weight heparin on the proliferative response after implantation of a balloon-expandable tantalum stent in previously deendothelialized coronary artery segments of hypercholesterolemic minipigs.
Minipigs were fed a diet containing 2% cholesterol, starting 1 month before balloon denudation of the endothelium in a coronary artery. One month later, a stent was implanted at this site. Animals were killed after 4 weeks (group 1, n = 6) or 3 months (group 2, n = 6). Animals in group 3 (n = 6), also followed for 4 weeks after stenting, received subcutaneous low-molecular-weight heparin at a dose of 200-300 units/kg anti-factor Xa activity per day in addition to the chronic acetylsalicylic acid (100 mg/day) also administered to groups 1 and 2. Eighteen of 22 animals survived to the end of the study. Angiography revealed patent stents in all surviving animals. In group 1, histological analysis showed extensive neointimal proliferation around stent struts. Maximal neointimal thickness seen in group 1 averaged 0.93 +/- 0.11 mm, was lower after 3 months (0.8 +/- 0.14 mm) in group 2, but was significantly reduced (0.44 +/- 0.18 mm, p less than 0.01) in group 3.
These data show a significant reduction of the neointimal proliferative response to coronary stent implantation by low-molecular-weight heparin.